Duration of Contact, Type of Leprosy, And Floor Condition As Risk Factors For Leprosy Sero-positivity

Muhamad Zen Rahfiludin, Lintang Dian Saraswati, Praba Ginandjar

Abstract

The high number of leprosy seropositivity in a population may lead to clinical leprosy. This study aimed to identify risk factors of leprosy. This study was conducted in Brondong, Lamongan, East Java. The subjects were 153 people who lived with leprosy patient. lgM anti PGL-1 level was examined used ELISA (Dako). Logistic regression was conducted to test the independent variables. The results showed that the subjects had an average age 31 year (6.5), average BMI 22 (2.9) and average IgM anti PGL-1 level 1041 unit/ml (820). 79.7% of the research subjects were women. The subjects house floor condition (p value 0.009) was the most influential variable to seropositivity of leprosy. Our findings indicated that not only the duration of leprosy and the contacts need to be considered in the transmission of leprosy, but also environmental factors, such as the subjects house floor condition.

Keywords

Seropositive leprosy; house floor condition; duration of contact

Full Text:

PDF

References

Adalid-Peralta, L. et al. 2011. Mechanisms underlying the induction of regulatory T cells and its relevance in the adaptive immune response in parasitic infections. Int J Biol Sci, 7(9) : 14121426.

Barreto, J.G. et al. 2011. Anti-PGL-I seroepidemiology in leprosy cases: household contacts and school children from a hyperendemic municipality of the Brazilian Amazon. Leprosy review, 82(4) : 35870.

Carvalho, A.P.M. et al. 2015. Factors associated with anti-phenolic glycolipid-I seropositivity among the household contacts of leprosy cases. BMC infectious diseases, 15 : 219.

Desikan, K. V, 1977. Viability of Mycobacterium leprae outside the human body. Leprosy review, 48(4) : 231

Desikan, K. V & Sreevatsa, 1995. Extended studies on the viability of Mycobacterium leprae outside the human body. Leprosy review, 66(4) : 28795. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8637382 [Accessed March 31, 2017].

Douglas, J.T. et al. 2004. Prospective study of serological conversion as a risk factor for development of leprosy among household contacts. Clinical and Diagnostic Laboratory Immunology, 11(5) : 897900.

Dppre, N.C. et al. 2012. Impact of PGL-I Seropositivity on the Protective Effect of BCG Vaccination among Leprosy Contacts: a Cohort Study. PLoS Neglected Tropical Diseases, 6(6) : 1711.

Durrheim, D.N. et al. 2002. Leprosy in Mpumalanga Province, South Africa--eliminated or hidden? Leprosy Review, 73(4) : 32633.

Feenstra, S.G. et al. 2011. Recent Food Shortage Is Associated with Leprosy Disease in Bangladesh: A Case-Control Study R. O. Phillips, ed. PLoS Neglected Tropical Diseases, 5(5) : 1029

Fitness, J., Tosh, K. & Hill, A.V.S., 2002. Genetics of susceptibility to leprosy. Genes and Immunity, 3(8) : 441453.

Frota, C.C. et al. 2010. Seropositivity to Anti-Phenolic Glycolipid-I in Leprosy Cases, Contacts and No Known Contacts of Leprosy in an Endemic and a Non-endemic Area in Northeast Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene, 104(7) : 4905.

Goulart, I.M.B. et al. 2008. Risk and Protective Factors for Leprosy Development Determined by Epidemiological Surveillance of Household Contacts. Clinical and Vaccine Immunology : CVI, 15(1) : 101

Hegazy, A.A. et al. 2002. Leprosy in a High-Prevalence Egyptian Village: Epidemiology and Risk Factors. International Journal of Dermatology, 41(10) : 681

Kerr-Pontes, L.R. et al. 2006. Socioeconomic, Environmental, and Behavioural Risk Factors for Leprosy in North-east Brazil: Results of a Case-Control Study. International Journal of Epidemiology, 35(4) : 9941000.

Lastria, J.C. & Abreu, M.A.M.M. de, 2014a. Leprosy: Review of the Epidemiological, Clinical, and Etiopathogenic Aspects - Part 1. Anais Brasileiros de Dermatologia, 89(2) : 20518.

Lastria, J.C. & Abreu, M.A.M.M. de, 2014b. Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - part 1. Anais brasileiros de dermatologia, 89(2) : 205

Lavania, M. et al. 2008. Detection of Viable Mycobacterium Leprae in Soil Samples: Insights into Possible Sources of Transmission of leprosy. Infection, Genetics and Evolution, 8(5) : 627631.

Matsuoka, M. et al. 2017. Mycobacterium Leprae DNA in Daily Using Water as a Possible Source of Leprosy Infection. Indian Journal of Leprosy, 71(1) : 61.

Moet, F. et al. 2004. Risk Factors for Development of Clinical Leprosy among Contacts and Their Relevance for Targeted Interventions. Leprosy Review, 75(4) : 310326.

Moet, F.J. et al. 2006. Physical Distance, Genetic Relationship, Age, and Leprosy Classification Are Independent Risk Factors for Leprosy in Contacts of Patients with Leprosy. The Journal of Infectious Diseases, 193(3) : 346353.

Muharry, A., 2014. Faktor Risiko Kejadian Kusta. KEMAS Jurnal Kesehatan Masyarakat, 9(2) : 174182

Nagar, N., 2007. Serum Profile Of Zinc , Copper And Magnesium In Lepromatous Leprosy A Case Control Study.

Penna, M.L.F. et al. 2016. Anti-PGL-1 Positivity as a Risk Marker for the Development of Leprosy among Contacts of Leprosy Cases: Systematic Review and Meta-analysis. PLoS Neglected Tropical Diseases, 10(5) : 0004703.

Rahfiludin, M.Z. et al. 2007. The Difference of Anti Phenolic Glycolipid-1 (PGL-1) Immunoglobulin-M (IgM) Level and Nutritional Intake in Subclinical Leprosy Patients who Reside at Home and in The Orphanage. Medical Journal of Indonesia, 16(4) : 224

Reinar Liv, M. et al. 2008. Interventions for Skin Changes Caused by Nerve Damage in Leprosy. Cochrane Database of Systematic Reviews, (3)

Schuring, R.P. et al. 2006. Association between Anti-pGL-I IgM and Clinical and Demographic Parameters in Leprosy. Leprosy Review, 77(4) : 343

Silva, R.C. da et al. 2008. The Result Patterns of ML Flow and ELISA (PGL-I) Serologic Tests in Leprosy-Endemic and Non-Endemic Areas. Revista da Sociedade Brasileira de Medicina Tropical, 41 Suppl 2 : 1922.

Sujagat, A. et al. 2015. Penemuan Kasus Infeksi Kusta Subklinis pada Anak melalui Deteksi Kadar Antibodi (IgM) anti PGL-1. Kesmas: National Public Health Journal, 10(2) : 74.

World Health Organization, 2012. Global leprosy situation, Geneva: World Health Organization.

Refbacks

  • There are currently no refbacks.